Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

The Use of Biomarker Ferritin and Albumin As Well As HCT-CI, but Not PAM, Was Predictive of Suvival, Gvhd and, Relapse in Myeloid Malignancies

Gary Simmons, DO, Allison F. Scalora, MS, Roy T Sabo, PhD, Catherine H. Roberts, PhD, William B. Clark, MD, Harold M. Chung, MD, Amir A. Toor, MD, John M. McCarty, MD

Blood (2015) 126 (23): 5448.

https://doi.org/10.1182/blood.V126.23.5448.5448

Published: 2015

Journal Articles

Lymphocyte Recovery Kinetics in Patients Undergoing Myeloablative Conditioning and Allogeneic Stem Cell Transplantation

David Jared Kobulnicky, MD, Roy T Sabo, PhD, Ali S Shubar Ali, BS, Catherine H. Roberts, PhD, Allison F Scalora, MS, Kristen M Kobulnicky, MS, Shiyu Song, MDPhD, William B. Clark, MD, Harold M. Chung, MD, John M. McCarty, MD, Michael C. Neale, PhD, Amir A. Toor, MD

Blood (2015) 126 (23): 5467.

https://doi.org/10.1182/blood.V126.23.5467.5467

Published: 2015

Journal Articles

Favorable T Cell Reconstitution In Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation with Low-Dose Rabbit Anti-Thymocyte Globulin and Total Body Irradiation

Radhika Thorn, MD, Jeremy Meier, BS, Elaine Wang, MD, Roy T Sabo, PhD, Allison F Scalora, MS, Catherine H Roberts, PhD, Shiyu Song, MD, PhD, Masoud H Manjili, DVM, PhD, William B Clark, MD, John M McCarty, MD, Harold M Chung, MD, Amir A Toor, MD

Blood (2013) 122 (21): 4577.

https://doi.org/10.1182/blood.V122.21.4577.4577

Published: 2013

Journal Articles

Immune Reconstitution In Anti-Thymocyte Globulin Conditioned Unrelated Donor Stem Cell Transplantation

David Jared Kobulnicky, MD, Roy T Sabo, PhD, Allison F Scalora, MS, David Portier, MD, Devon Fletcher, MD, Jeffrey M Tessier, MD, William B Clark, MD, Harold M Chung, MD, John M McCarty, MD, Catherine H Roberts, PhD, Amir A Toor, MD

Blood (2013) 122 (21): 2071.

https://doi.org/10.1182/blood.V122.21.2071.2071

Published: 2013

Journal Articles

FLAG ± Idarubicin Compared with 7+3 As Initial Induction for Secondary Acute Myeloid Leukemia: A Single Institution Experience

Jenny Li, Pharm.D., BCPS, Mandy L Gatesman, Pharm.D., BCOP, Ashley M Newland, Pharm.D., BCOP, Roy T Sabo, PhD, Prithviraj Bose, MD

Blood (2012) 120 (21): 4330.

https://doi.org/10.1182/blood.V120.21.4330.4330

Published: 2012

Journal Articles

Optimizing Outcomes in Multiple Myeloma Using Risk Stratified Allocation to Single Versus Tandem Autologous SCT.

Matthew Risendal, BS, Roy T Sabo, PhD, Allison F Hazlett, MS, Priscilla Mpasi, BS, Joan Bolling, William B Clark, MD, John M McCarty, MD, Harold M Chung, MD, Catherine H Roberts, PhD, Amir A Toor, MD

Blood (2012) 120 (21): 3123.

https://doi.org/10.1182/blood.V120.21.3123.3123

Published: 2012

Journal Articles

Favorable Outcomes in Patients with High Donor-Derived T Cell Count Following In Vivo T Cell Depleted Reduced Intensity Allogeneic Stem Cell Transplantation

Amir A Toor, MD, Roy T Sabo, PhD, Harold M Chung, MD, Catherine H Roberts, PhD, Rose H Manjili, BS, Shiyu Song, MD, PhD, David C. Williams, Jr., MD, PhD, William Clark, MD, Masoud H Manjili, DVM, PhD, John M McCarty, MD

Blood (2011) 118 (21): 3043.

https://doi.org/10.1182/blood.V118.21.3043.3043

Published: 2011

Journal Articles

Adaptive Immunotherapy In Multiple Myeloma: Epigenetic Modification and Immunomodulation by Sequential Azacitidine and Lenalidomide to Generate Cancer Testis Antigen Specific Cellular Immune Response

Amir A Toor, MD, Kyle Payne, BS, Harold M Chung, MD, Catherine H Roberts, PhD, Roy T Sabo, PhD, Maciej Kmieciak, PhD, William Clark, MD, Christy McLaughlin, BS, Angela Buskey, RN, Jennifer Anderson, RN, Rose H Manjili, BS, Susan D. Roseff, MD, John M McCarty, MD, Masoud H Manjili, DVM, PhD

Blood (2011) 118 (21): 2926.

https://doi.org/10.1182/blood.V118.21.2926.2926

Published: 2011

NARROW

The Use of Biomarker Ferritin and Albumin As Well As HCT-CI, but Not PAM, Was Predictive of Suvival, Gvhd and, Relapse in Myeloid Malignancies

Lymphocyte Recovery Kinetics in Patients Undergoing Myeloablative Conditioning and Allogeneic Stem Cell Transplantation

Favorable T Cell Reconstitution In Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation with Low-Dose Rabbit Anti-Thymocyte Globulin and Total Body Irradiation

Immune Reconstitution In Anti-Thymocyte Globulin Conditioned Unrelated Donor Stem Cell Transplantation

FLAG ± Idarubicin Compared with 7+3 As Initial Induction for Secondary Acute Myeloid Leukemia: A Single Institution Experience

Optimizing Outcomes in Multiple Myeloma Using Risk Stratified Allocation to Single Versus Tandem Autologous SCT.

Favorable Outcomes in Patients with High Donor-Derived T Cell Count Following In Vivo T Cell Depleted Reduced Intensity Allogeneic Stem Cell Transplantation

Adaptive Immunotherapy In Multiple Myeloma: Epigenetic Modification and Immunomodulation by Sequential Azacitidine and Lenalidomide to Generate Cancer Testis Antigen Specific Cellular Immune Response

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only